By PBN staff
PROVIDENCE – EpiVax Inc. said Tuesday it has received a $458,000, two-year grant to develop a universal influenza vaccine.
“There is an urgent, unmet need for an influenza vaccine with greater potency and wider application to diverse flu viruses that can also be developed more rapidly than conventional influenza vaccines,” said Dr. Annie De Groot, CEO and CSO of EpiVax, which is based in the Capital City’s Knowledge District.
Leave a Reply